📰 Kures Inc News

Kures Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Kures Inc. Real-time updates on events, politics, business and more.

Acute Pain Pipeline, Clinical and Non-Clinical Stages Products, and FDA Approvals 2023 (Updated)

September 27, 2023

DelveInsights, Acute Pain Pipeline Insight 2023 report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Acute Pain pipeline landscape. It covers the Acute Pain...

United States Yash Bhardwaj Las Vegas Xgene Pharmaceutical Group Kures Inc Elysium Therapeutics Inc

Source: marketscreener.com

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

December 23, 2022

Investegate announcements from atai Life Sciences, atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

Stephen Bardin Allan Malievsky Xlife Sciences Company Columbia University Exchange Commission Kures Inc

Source: investegate.co.uk

atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

December 23, 2022

- This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 - KUR-101 was well tolerated and demonstrated analgesic

Stephen Bardin Allan Malievsky Exchange Commission Kures Inc Life Sciencesnv Nasdaq Life Sciences

Source: finanznachrichten.de

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD

October 12, 2022

Investegate announcements from atai Life Sciences, atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD

Chad Beyer Stephen Bardin Allan Malievsky Exchange Commission Kures Inc Life Sciencesnv Nasdaq